-
Global Access Licensing: An Expert Interview Study with Scientists-Inventors and Directors of Technology Transfer Offices Involved in the Development and Commercialization of COVID-19 Vaccines
Sep 9, 2025, 16:22 PM -
The Uptake of R in NICE HTA: Insights From Technology Assessment Groups
Sep 9, 2025, 16:22 PM -
Descriptive Comparison of Patient Characteristics and Treatment Patterns in Metastatic NSCLC: US and France Cohorts to Inform Transportability
Sep 9, 2025, 16:22 PM -
Instrumental Variable Treatment Effects Estimation: A Simulation Comparison of Instrumental Variables and OLS Approaches
Sep 9, 2025, 16:22 PM -
The Impact of Inflation: A Cost Analysis in the Spanish Pharmaceutical Sector From 2014 to 2023
Sep 9, 2025, 16:22 PM -
Genomic Testing for Early Breast Cancer: Assessing the Value of Next-Generation Sequencing
Sep 9, 2025, 16:22 PM -
Epidemiology and Institutional Treatment Distribution of Patients With Myelofibrosis (MF) in Germany: Insights From a Real-World Evidence Study
Sep 9, 2025, 16:22 PM -
Trends in Reimbursement Agreements for Innovative Orphan and Oncological Medicines in Spain 2020-2025
Sep 9, 2025, 16:22 PM -
Advancing Target Trial Emulation With Synthetic Data: The Target Trial Optimization Framework
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization and Costs Among Bacillus Calmette-Guérin (BCG)-Experienced or Unresponsive Patients With Papillary-Only High-Risk Non–Muscle Invasive Bladder Cancer
Sep 9, 2025, 16:22 PM -
Scoping the Future: Using NICE Scopes to Inform PICO Prediction for EU Joint Clinical Assessment
Sep 9, 2025, 16:22 PM -
The Burden and Management of Flares Among Pregnant Patients With Generalized Pustular Psoriasis (GPP): Real-World Evidence (RWE) From the Global SCRIPTOR Study
Sep 9, 2025, 16:22 PM -
Zoom Out: Simplifying Complex Health Economic Model Structure Through Artificial Intelligence
Sep 9, 2025, 16:22 PM -
Exit Strategies in Patients With Stable MS: Cost-Effectiveness of Extended Interval Dosing of Ocrelizumab and Natalizumab vs. De-escalating to Cladribine
Sep 9, 2025, 16:22 PM -
The SISAQOL-IMI Recommendations on Standardizing the Use of Thresholds for Interpretation of Patient-Reported Outcome Results in Cancer Clinical Trials
Sep 9, 2025, 16:22 PM -
Patient Perspectives on Disease Experiences and Value of Real-Time Self-Reported Symptom and Treatment Monitoring in Locally Advanced and Metastatic Breast Cancer
Sep 9, 2025, 16:22 PM -
Managed Reimbursement of Continuous Glucose Monitoring Sensors in Ireland: Year One Review
Sep 9, 2025, 16:22 PM -
Fitting Flexible Survival Models to Landmark Survival Estimates in R
Sep 9, 2025, 16:22 PM -
Accelerating Therapeutic Innovation: Early Results From France’s Accès Direct Scheme
Sep 9, 2025, 16:22 PM -
Optimal Utilization of Robotic-Assisted Surgery in the NHS: A System-Level Economic Evaluation Model
Sep 9, 2025, 16:22 PM
